Cargando…
Review of Mechanisms, Pharmacological Management, Psychosocial Implications, and Holistic Treatment of Pain in Fabry Disease
Fabry disease is a progressive X-linked lysosomal storage disease caused by a mutation in the GLA gene, encoding the lysosomal hydrolase α-galactosidase A. The consequent reduced enzyme activity results in the toxic accumulation of glycosphingolipids, particularly globortriaosylceramide (Gb3 or GL(3...
Autores principales: | Rajan, Jonathan Niranjan, Ireland, Katharine, Johnson, Richard, Stepien, Karolina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472766/ https://www.ncbi.nlm.nih.gov/pubmed/34575277 http://dx.doi.org/10.3390/jcm10184168 |
Ejemplares similares
-
Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel
por: Stepien, Karolina M., et al.
Publicado: (2023) -
Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment
por: Ganguly, Pronab, et al.
Publicado: (2018) -
The Holistic Approach to Cancer Pain Management
por: Hussain, Zobia
Publicado: (2022) -
Lipid profile in adult patients with Fabry disease - Ten-year follow up
por: Stepien, Karolina M., et al.
Publicado: (2017) -
Pharmacological chaperone therapy for Fabry disease
por: ISHII, Satoshi
Publicado: (2012)